---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-001044"
form_type: "8-K"
ticker: "PLSE"
cik: "0001625101"
company_name: "PULSE BIOSCIENCES, INC."
filed_at: "2025-01-14T23:59:59+00:00"
generated_at: "2026-05-28T02:04:35.803368+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# Pulse Biosciences posts updated investor deck highlighting CellFX nsPFA device progress

## Summary
- Updated deck discloses progress on CellFX nsPFA 360 Cardiac Catheter development.
- Progress also detailed for CellFX nsPFA Cardiac Clamp and Percutaneous Electrode.
- Presentation dated January 2025; posted on company website under Investors.

## SEC filing metadata
- accession: 0001437749-25-001044
- form_type: 8-K
- ticker: PLSE
- cik: 0001625101
- company_name: PULSE BIOSCIENCES, INC.
- filed_at: 2025-01-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625101/000143774925001044/0001437749-25-001044-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625101/000143774925001044/plse20250114_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-001044
- JSON: https://secwatch.observer/filing/0001437749-25-001044.json
- Plain text: https://secwatch.observer/filing/0001437749-25-001044.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.